COMPANY PROFILE -Novavax Inc.
Business Sector :Pharmaceutical, Healthcare
Operating Geography :United States, North America, Global
About Novavax Inc. :
Novavax Inc., is an American biotechnology company headquartered in Gaithersburg, Maryland. Novavax Inc., was initially founded to focus on the development of experimental vaccines and was established in 1987. It promotes improved health globally by discovering and developing innovative vaccines. The company develops and commercializes vaccines which help in preventing serious infectious diseases. Prior to 2020, the company's scientists developed vaccines for diseases such as Ebola, Respiratory Syncytial Virus (RSV), and influenza and later it refocused its efforts and concentrated on developing COVID-19 vaccines in 2020. The firm has thus taken steps for ensuring the continued advancement of its influenza vaccine. It has been honoured with fast-track status in January 2020, by the U.S. Food and Drug Administration (FDA) for NanoFlu. In January 2021, the company announced the results of phase 3 trials that showed 89 percent efficacy against Covid-19. The vaccine also provides high immunity against novel variations, according to the report. Novavax, Inc. announced in April 2022 that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of the NuvaxovidTM (NVX-CoV2373) COVID-19 vaccine as a booster in people aged 18 and up.
Novavax Inc.'s Unique Selling Point or USP lies in it being one of the most advanced vaccine development businesses in the world. Recombinant Nanoparticle Vaccine Technology and Matrix-M adjuvant Technology are two of the company's exclusive innovations. Novavax's vision statement reads, “Our vision is a resilient Joint Force enabled to fight and win, unencumbered by a chemical, biological, radiological, or nuclear environment".
Novavax Inc. Revenue :
US$ 1.1 billion - FY ending 31st December 2021 (131% y-o-y growth)
US$ 475.6 million - FY ending 31st December 2020 (2456% y-o-y growth)
US$ 18.6 million - FY ending 31st December 2019
Competitive Analysis of Novavax Inc.
The SWOT analysis for Novavax is presented below in a matrix followed by the detailed analysis report:
| Strengths | Weaknesses |
1. Unique process for vaccine development
2. Diversified medicines for multiple diseases
3. Numerous patents and patent laws keep the company in the forefront
4. Strategic alliances with various bodies to ensure better drug development across the world
| 1. Dependence on third party for testing and trials
2. Numerous government regulations increase operational costs for the company
3. FDA approval process takes a long time which limits ability of the company to launch new drugs quickly
4. Uncertainty over funding for the company’s COVID vaccine
|
| Opportunities | Threats |
1. Covid vaccination drives in USA and other nations will drive revenues for the company
2. Getting involved in vaccination of underdeveloped countries and expanding its vaccine portfolio
| 1. Intense competition from other drug manufacturers may affect profits for the company
2. Commercial success of vaccine candidates are uncertain due to uncertainty over prices and reimbursements
|
On purchase the Novavax Inc. SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed SWOT Analysis of Novavax Inc.
Strength
This section is available only in the 'Complete Report' on purchase.
Weakness
1. Dependence on third party for testing and trials: Novavax is highly dependent on third-party organizations to conduct some of our laboratory testing and clinical trials and a significant amount of our vaccine manufacturing activities and distribution. If the company is unable to obtain any necessary services on acceptable terms, it may not complete its product development efforts in a timely manner. The company may lose some control over these activities or become too dependent upon these parties. Certain of Novavax’s facilities are also contracted for defined time frames and through association with OWS and CEPI, and may not be available for sufficient periods of time to adequately supply its products. The FDA and foreign regulatory agencies require the company to comply with regulations and standards, commonly referred to as good clinical practices, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, safety and welfare of clinical trial participants are adequately protected. The FDA and foreign regulatory agencies also require the company to comply with good manufacturing practices. These regulations make its dependence on third parties for critical parts of the drug development process a liability which may lead to unnecessary delays or may be fines if things do not pan out properly for the company.
The remaining section under "Weakness" is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for Novavax is presented below in a table followed by the detailed analysis report:
| Political | Economical |
1. Impact of Biden administration on the pharmaceutical industry
2. US-China trade war affects the pharmaceutical industry by supply chain disruptions
| 1. Impact of COVID-19 on pharmaceutical industry in USA |
| Social | Technological |
| 1. Vaccination drives for COVID and other diseases continue which would generate revenues for drug makers | 1. Use of AI and ML in the development of drugs in USA
2. Digitalization of the drug manufacturing process in the pharma sector
3. Developing next-generation flu vaccine for improved protection
|
| Legal | Environmental |
1. Pharmaceutical and FDA regulations for new drug development
2. Patent laws and its protection in USA
| 1. Impact of climate change on US’s pharmaceutical industry |
On purchase the Novavax Inc. SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed Pestle Analysis of Novavax Inc.
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
This section is available only in the 'Complete Report' on purchase.
Technological
1. Use of AI and ML in the development of drugs in USA: Artificial intelligence in Pharma refers to the use of automated algorithms to perform tasks which traditionally rely on human intelligence. Over the last five years, the use of artificial intelligence in the pharma and biotech industry has redefined how scientists develop new drugs, tackle disease, and more. Furthermore, according to Narrative Science, 61% of companies investing in innovative strategies are using AI to identify opportunities that they would have otherwise missed. A study published by the Massachusetts Institute of Technology (MIT) has found that only 13.8% of drugs successfully pass clinical trials. Furthermore, a company can expect to pay between $161 million to $2 billion for any drug to complete the entire clinical trials process and get FDA approval. With this in mind, pharma businesses such as Novavax are using AI to increase the success rates of new drugs while decreasing operational costs at the same time. AI and ML have been used during COVID times for disease identification, digital therapeutics, drug discovery and manufacturing and in clinical trials. ML and AI technologies are also being applied to monitoring and predicting epidemic outbreaks or seasonal illnesses worldwide. A predictive forecast helps plan our supply chain to get the inventory at the right time and the right quantity based on the predicted intensity.
The remaining section under "Technological" is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Brands :
- NanoFlu
- ResVax
- NVX-CoV2373
On purchase the Novavax Inc. SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Novavax Inc.:
-
| Novavax Inc. Porter's Five Forces Analysis |
|
-
| Novavax Inc. VRIO Analysis |
|
-
| Novavax Inc. Value Chain Analysis |
|
-
| Novavax Inc. Covid-19 Impact Analysis |
|
-
| Novavax Inc. BCG Analysis |
|
-
| Novavax Inc. Segmentation, Targeting and Positioning (STP) Analysis |
|
-
| Novavax Inc. Ansoff Matrix Analysis |
|
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Novavax Inc. SWOT & PESTLE Analysis Report
1. Annual Report - https://ir.novavax.com/static-files/576c461a-c3af-4c3e-bf9a-ecc9cf251d1c
2. About Us - https://www.novavax.com/about-us
3. FDA Approval Process - https://www.drugwatch.com/fda/approval-process/#:~:text=The%20FDA%20aims%20to%20get,do%20not%20have%20adequate%20treatment.
4. Biden administration – What can the healthcare industry expect - https://pharmaphorum.com/views-and-analysis/biden-administration-what-can-the-healthcare-industry-expect/
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Novavax Inc. SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2025). Novavax Inc. SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/novavax-inc/ [Accessed 14 Feb, 2025].
In-text: (SWOT & PESTLE.com, 2025)
Copyrights and Disclaimer
Novavax Inc. SWOT and PESTLE analysis has been conducted by Amit Kabi and reviewed by senior analysts from Barakaat Consulting.
Copyright of Novavax Inc. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.
Safe and secure payments
